A Novel Paradigm for the Treatment of Osteoarthritis

At TissueGene, we are developing advanced cell therapies to target various orthopedic diseases and degenerative disorders.

explore our platform technology
An Allogeneic Cell and Gene Therapy for Osteoarthritis of the Knee

An Allogeneic Cell and Gene Therapy for Osteoarthritis of the Knee

INVOSSA™ (TG-C)is designed to conveniently and effectively treat osteoarthritis of the knee by reducing pain, increasing function, and slowing the progression of the disease.

learn more about invossa
Developing Advanced Cell Therapies for the Treatment of Orthopedic Disorders and Unmet Medical Needs

Developing Advanced Cell Therapies for the Treatment of Orthopedic Disorders and Unmet Medical Needs

TissueGene is a Maryland-based biopharmaceutical company developing clinical-stage advanced cell therapies.

INVOSSA™